Copyright
©The Author(s) 2015.
World J Respirol. Jul 28, 2015; 5(2): 65-68
Published online Jul 28, 2015. doi: 10.5320/wjr.v5.i2.65
Published online Jul 28, 2015. doi: 10.5320/wjr.v5.i2.65
Experiment period | The formation of pathology takes hours or days in humans, whereas the monitored period is shorter in animal models (monitoring difficulties) |
Ventilation and fluid management | Ventilation and fluid management supports are lacking in animal experiments (these are crucial in humans) |
The degree of pathology | Experimental models generally have milder pathology compared to human pathology |
The species and the size of the animals | Larger animals (primates) can more easily mimic human disease, but these experiments require expertise. Smaller animals (mice) are much more widely used (this may allow for the study of complex pathways and genetic studies) |
Treatment time | Therapeutic agents in experimental studies are usually given before the onset of acute respiratory distress syndrome, whereas the clinical diagnosis and treatment of ARDS is delayed |
Animal age | Animal experiments are performed on young animals with no comorbidities; however, patients with ARDS are mostly elderly and may have many medical problems such as cardiovascular diseases, kidney or liver failure |
Changes in response to therapy | The effects of therapeutic agents on survival in humans and animals are different. An agent may be effective on animal survival, but may not be effective in humans (there are many anatomical and physiological differences between animals and humans) |
Coagulation and fibrinolytic status | Animal models cannot mimic the coagulation and fibrinolytic system changes during lung injury in humans |
Correlation between biochemical markers and their biological activities | Biochemical markers measured in bronchoalveolar lavage fluid, plasma and edema fluid may not correlate with their biological activities |
Combination treatment | Combined treatment should be developed. Combined treatment approaches are applied to a lesser extent in experimental models |
- Citation: Yilmaz Sipahi E. Causes of failure in acute respiratory distress syndrome modeling and treatment in animal research and new approaches. World J Respirol 2015; 5(2): 65-68
- URL: https://www.wjgnet.com/2218-6255/full/v5/i2/65.htm
- DOI: https://dx.doi.org/10.5320/wjr.v5.i2.65